The prospect of substrate-based kinase inhibitors to improve target selectivity and overcome drug resistance

Abstract excerpt

Human kinases are recognized as one of the most important drug targets associated with cancer. There are >80 FDA-approved kinase inhibitors to date, most of which work by inhibiting ATP binding to the kinase. However, the frequent development of single-point mutations within the kinase domain has made overcoming drug resistance a major challenge in drug discovery today. Targeting the substrate site of kinases can...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cancer Mechanisms and Therapy
• Share to PI3K/AKT/mTOR signaling in cancer
• Share to Protein Kinase Regulation and GTPase Signaling